Reported 1 day ago
Zimmer Biomet announced it will acquire Paragon 28 for approximately $1.1 billion to enhance its range of orthopedic surgical devices. This acquisition will enable Zimmer Biomet to access Paragon's foot and ankle surgical implants while strengthening its fracture and trauma, and joint replacement sectors. The deal includes a cash payment of $13.00 per share, a premium of 8.3% over Paragon's recent closing price, and may raise the total value to about $1.2 billion depending on performance. The transaction is set to close in the first half of 2025.
Source: YAHOO